Sage Therapeutics Inc. (SAGE)

NASDAQ: SAGE · Real-Time Price · USD

7.27

-0.21 (-2.81%)

At close: May 02, 2025, 3:59 PM

7.28

0.14%

After-hours: May 02, 2025, 04:07 PM EDT

Sage Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-400.67M	-541.49M	-532.78M	-457.89M	606.07M	-680.24M	-372.88M	-270.12M	-158.99M
Depreciation & Amortization	-5.45M	1.39M	1.12M	4.18M	2.63M	2.28M	1.14M	531K	281K
Stock-Based Compensation	54.5M	73.37M	61.6M	104.63M	95.99M	153.23M	101.96M	35.53M	23.02M
Other Working Capital	8.51M	-58.89M	-2.76M	-6.69M	-28.22M	25.44M	-5.33M	18.87M	9.68M
Other Non-Cash Items	-344K	-6.47M	4.35M	-10.6M	-688K	-10.64M	-10.11M	-398K	-470K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	84.76M	-67.38M	5.67M	-18.51M	-39.73M	6.66M	19.21M	15.18M	17.48M
Operating Cash Flow	-267.19M	-540.59M	-460.04M	-378.18M	664.28M	-528.71M	-260.67M	-219.28M	-118.68M
Capital Expenditures	n/a	-553K	-937K	-372K	-345K	-5.75M	-2.86M	-1.36M	-1.42M
Cash Acquisitions	n/a	n/a	-326.37M	1B	-443.03M	137.41M	n/a	n/a	n/a
Purchase of Investments	-450.96M	-594.67M	-881.04M	-1.99B	-458.72M	-1.31B	-1.48B	-244.4M	-259.09M
Sales Maturities Of Investments	717.63M	1.04B	1.21B	988.08M	901.75M	1.17B	974.76M	261.23M	30.5M
Other Investing Acitivies	n/a	n/a	326.37M	-1B	443.03M	-137.41M	-509.6M	-285K	-525K
Investing Cash Flow	266.68M	442.91M	325.43M	-1B	442.68M	-143.16M	-512.46M	15.18M	-230.54M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	-903K	-43K	-1.39M	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2.5M	6.03M	3.07M	13.33M	9.26M	46.35M	27.86M	15.79M	807K
Financial Cash Flow	10.66M	6.03M	3.07M	13.33M	426.76M	607.62M	659.36M	341.82M	330.98M
Net Cash Flow	10.15M	-91.64M	-131.53M	-1.37B	1.53B	-64.24M	-113.77M	137.72M	-18.24M
Free Cash Flow	-267.19M	-541.14M	-460.97M	-378.55M	663.93M	-534.46M	-263.53M	-220.64M	-120.1M